Company
TORL Biotherapeutics
Advancing novel antibody-based therapies to transform the lives of cancer patients.
Also known as TORL BioTherapeutics, LLC
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Culver City, CA, United States
- Legal name
- TORL BioTherapeutics, LLC
Claim, correct or request removal
Record updated 28 September 2026
About
TORL BioTherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer worldwide.
Funding snapshot
- Total raised
- $158MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $158M2024-04-04
Funding rounds
- Round, 2024
- $158M2024-04-04, SEC form D sold, 52 investors
Products
- Other
- Ixotatug Vedotin (Ixo-V; TORL-1-23)
- Other
- TORL-4-500
- Other
- TORL-5-700
Loading relationship preview